Entera Bio Ltd. (ENTX) closed at $1.98 in the latest trading session, marking a -1% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 1.02%. Meanwhile, the Dow ...

Entera Bio Ltd. (ENTX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...

Entera Bio ENTX shares have rallied about 34.5% over the past month, driven by investor optimism after the company received positive FDA feedback on the phase III registrational study design for EB613 ...

Good morning everyone and thank you for joining us. My name is Yehuda Leibler from Entera's Investor Relations team and I'll be hosting today's discussion on behalf of the company. Today's event will ...

Entera Bio Ltd. ENTX and OPKO Health, Inc. OPK recently announced positive topline pharmacokinetic/pharmacodynamic (PK/PD) results from their ongoing collaborative ...